print-logo

"You get access to a senior consulting team who has deep competency and experience in their respective areas."

– Global Top 10 Pharma, Director Medical Affairs

Find out what our clients think about us

How Medical Affairs has evolved into a leading function

 

Discover Medical Affairs

Learn how we can help you to drive leadership in Medical Affairs

Learn about our offering

Contact us

 

Engage with our experts

Browse through our perspectives on how to maximize Medical Affairs

Explore our publications and case studies
Logo
  • Healthcare Consultants
  • Healthcare Managers
  • Who we are Arrow Down
    • About us
    • Our team
    • News & events
  • What we do Arrow Down
    • Overview
    • Market Access
    • Medical Affairs
    • Government Affairs
    • Commercial Excellence
    • Patient Affairs
    • Healthcare Improvement
  • Insights Arrow Down
    • Publications
    • Project cases
    • Early Asset Strategy
    • Value Pull-through
    • Environment Transformation
  • Careers Arrow Down
    • Why join us
    • FAQ
  • Contact
  • Search Icon
  • Healthcare Consultants
  • Healthcare Managers
  • Search Icon
  • Search
Back to What we do
  • linkedin_icon
  • mail_icon
  • print_icon

Medical Affairs

We support Medical Affairs in playing a pivotal, strategic role in helping biopharmaceutical companies to build trusted partnerships, demonstrate the value of their products to a wide range of stakeholders and facilitate their appropriate use in practice.

You get access to a senior consulting team who has deep competency and experience in their respective areas.

– Global Top 10 Pharma, Director Medical Affairs

About Medical Affairs 

  • The importance of Medical Affairs has increased dramatically over the past few years from a supporting, reactive function to a central, strategic, customer-facing one. 
  • This is because in today’s increasingly patient outcome-focused healthcare environment, Medical Affairs is uniquely placed to work closely with all stakeholders, including as a preferred point of contact with healthcare professionals.
  • The function acts as a crucial bridge, strategically connecting clinical research and real-world clinical application, ensuring that innovative treatments are not only effective but also reach the patients who need them most. 
  • The role of Medical Affairs spans the product lifecycle, from early phase environmental transformation to ensure readiness for innovation, to shaping systems of care in later stages.

What our clients are working on

Medical Affairs is continuously evolving, with teams seeking to increase their impact through:

  • Functional Excellence: Advancing Medical Affairs leadership, elevating capabilities, building new skill sets and optimizing measurement of the function’s impact
  • Strategic Thinking: Delivering distinct Medical Affairs strategies that drive measurable impact on priorities unique to medical – including evidence generation, omnichannel education, medical information, and healthcare improvement 
  • Trusted Partner: Fostering strategic partnerships with the clinical community as trusted ambassadors of patient outcomes, from key opinion leaders to health systems and managed care organizations

We support Medical Affairs across its pivotal functions to play a strategic role in helping biopharmaceutical companies to build trusted partnerships, demonstrate the value of their products to a wide range of stakeholders and facilitate their appropriate use in practice.

Our Medical Affairs Services:

  • Future fit functional strategy & strengthened internal positioning
  • Organizational setup, operational excellence, and capability building
  • Impact measurement & reporting
Advance the Medical Affairs function
  • Therapy area & asset-related medical strategy development, incl. early asset strategy & clinical value proposition
  • Medical insight generation & cross-functional dissemination, incl. landscape scanning & assessments
  • Integrated Evidence Planning (IEP)
Drive medical strategy development & planning
  • Evidence sharing & medical education strategy
  • Digital (omni-) channel engagement planning
  • Strategic cross-stakeholder engagement through advisory boards, KOL engagement, and alternative innovative platforms
Facilitate scientific exchange
  • Care improvement strategy development to address system care gaps, disparities & health equity challenges
  • Partnership strategies with health systems & other medical institutions
  • Care pathway optimization approaches & toolkits
Enhance healthcare improvement

Contact our experts

Tanja Bosshard Becker

Tanja Bosshard Becker

Partner

mail_icon linkedin_icon
Lisa Clark

Lisa Clark

Principal

mail_icon linkedin_icon
Anthony Schläpfer

Anthony Schläpfer

Director

mail_icon linkedin_icon
Marc Pesse

Marc Pesse

Partner

mail_icon linkedin_icon
Arman Nilforoushan

Arman Nilforoushan

Director

mail_icon linkedin_icon

Related project cases and publications

How the ‘five Ps’ can close health equity gaps
Publication

How the ‘five Ps’ can close health equity gaps

Understanding and addressing healthcare inequity in the United States
Publication

Understanding and addressing healthcare inequity in the United States

Shifting the care paradigm for individuals with skin of color (SOC) in the United States
Publication

Shifting the care paradigm for individuals with skin of color (SOC) in the United States

Building relationships: How Medical Affairs can advance healthcare improvement
Publication

Building relationships: How Medical Affairs can advance healthcare improvement

Collaborative, evidence-based decisions the key for successful healthcare policy-making
Publication

Collaborative, evidence-based decisions the key for successful healthcare policy-making

Paving the way to healthcare equity: Raising awareness of existing gaps in the dermatologic care of diverse populations in the US
Publication

Paving the way to healthcare equity: Raising awareness of existing gaps in the dermatologic care of diverse populations in the US

  • Back
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • More

Early Asset Strategy

Early Asset Strategy

Value Pull-through

Value Pull-through

Environment Transforma­tion

Environment Transforma­tion
Share this page
  • linkedin_icon
  • mail_icon
  • print_icon

We use cookies to ensure we give you the best experience on our website. Detailed information on the use of cookies, and how you can disable them, is provided in our Privacy Policy. By using this site or clicking on "OK", you consent to the use of cookies.

OK
arrow_up

How can we help?

Contact us

Our offices

Careers

Footer Logo
  • Who we are
  • What we do
  • Insights
  • Careers
  • Contact
  • Terms of use
  • Privacy policy
  • Imprint

2025 Executive Insight. All rights reserved.